| Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease AA Kehagia, RA Barker, TW Robbins The Lancet Neurology 9 (12), 1200-1213, 2010 | 1126 | 2010 |
| Cognitive impairment in Parkinson’s disease: the dual syndrome hypothesis AA Kehagia, RA Barker, TW Robbins Neurodegenerative diseases 11 (2), 79-92, 2012 | 592 | 2012 |
| Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation AA Kehagia, GK Murray, TW Robbins Current opinion in neurobiology 20 (2), 199-204, 2010 | 462 | 2010 |
| Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication J Veijola, JY Guo, JS Moilanen, E Jääskeläinen, J Miettunen, M Kyllönen, ... PloS one 9 (7), e101689, 2014 | 156 | 2014 |
| Targeting impulsivity in Parkinson’s disease using atomoxetine AA Kehagia, CR Housden, R Regenthal, RA Barker, U Müller, J Rowe, ... Brain 137 (7), 1986-1997, 2014 | 154 | 2014 |
| Switching between abstract rules reflects disease severity but not dopaminergic status in Parkinson's disease AA Kehagia, R Cools, RA Barker, TW Robbins Neuropsychologia 47 (4), 1117-1127, 2009 | 68 | 2009 |
| Realising stratified psychiatry using multidimensional signatures and trajectories DW Joyce, AA Kehagia, DK Tracy, J Proctor, SS Shergill Journal of Translational Medicine 15, 1-30, 2017 | 41 | 2017 |
| Conflicting emergences. Weak vs. strong emergence for the modelling of brain function FE Turkheimer, P Hellyer, AA Kehagia, P Expert, LD Lord, J Vohryzek, ... Neuroscience & Biobehavioral Reviews 99, 3-10, 2019 | 37 | 2019 |
| Revisiting the effects of Parkinson's disease and frontal lobe lesions on task switching: The role of rule reconfiguration AA Kehagia, RA Barker, TW Robbins Journal of neuropsychology 8 (1), 53-74, 2014 | 22 | 2014 |
| Anais Nin: A case study of personality disorder and creativity AA Kehagia Personality and Individual Differences 46 (8), 800-808, 2009 | 22 | 2009 |
| From homeostasis to behavior: Balanced activity in an exploration of embodied dynamic environmental-neural interaction PJ Hellyer, C Clopath, AA Kehagia, FE Turkheimer, R Leech PLoS computational biology 13 (8), e1005721, 2017 | 21 | 2017 |
| Neuropsychiatric symptoms in Parkinson’s disease: beyond complications AA Kehagia Frontiers in Psychiatry 7, 110, 2016 | 18 | 2016 |
| More education, less administration: reflections of neuroimagers’ attitudes to ethics through the qualitative looking glass AA Kehagia, K Tairyan, C Federico, GH Glover, J Illes Science and engineering ethics 18, 775-788, 2012 | 16 | 2012 |
| Introducing the Parkinson’s KinetiGraph into Routine Parkinson’s Disease Care: A 3-Year Single Centre Experience T Dominey, AA Kehagia, T Gorst, E Pearson, F Murphy, E King, C Carroll Journal of Parkinson's Disease, 1-6, 2020 | 14 | 2020 |
| Parsing the roles of the frontal lobes and basal ganglia in task control using multivoxel pattern analysis AA Kehagia, R Ye, DW Joyce, OM Doyle, JB Rowe, TW Robbins Journal of cognitive neuroscience 29 (8), 1390-1401, 2017 | 11 | 2017 |
| Enhancing trial delivery in Parkinson’s disease: Qualitative insights from PD STAT AA Kehagia, TK North, J Grose, AN Jeffery, L Cocking, R Chapman, ... Journal of Parkinson's Disease 12 (5), 1591-1604, 2022 | 7 | 2022 |
| Real-world evaluation of the feasibility, acceptability and safety of a remote, self-management Parkinson’s disease care pathway: A healthcare improvement initiative AA Kehagia, S Chowienczyk, M Helena van Velthoven, E King, T North, ... Journal of Parkinson's disease, 1-12, 2024 | 6 | 2024 |
| The neurochemical modulation of prefrontal control processes TW Robbins, AA Kehagia The Wiley handbook of cognitive control, 334-354, 2017 | 5 | 2017 |
| THE EFFECT OF ATOMOXETINE ON IMPULSIVITY IN PARKINSON'S DISEASE CR Housden, A Kehagia, RA Barker, T Rittman, Y Faluyi, U Mueller, ... Journal of Psychopharmacology 25 (8), A29-A29, 2011 | 4 | 2011 |
| Mapping the effects of atomoxetine during response inhibition across cortical territories and the locus coeruleus R Ye, N Mazibuko, J Teichert, R Regenthal, AA Kehagia, MA Mehta Psychopharmacology, 1-12, 2022 | 3 | 2022 |
